7 VC firms investing in food & beverage and biotech & life sciences at the Growth stage.
F4 Fund tracks 7 VC firms that actively invest in food & beverage + biotech & life sciences at the Growth stage, with check sizes ranging from $100K – $340M (median: $5.3M – $5.3M). As of August 2026, and 86% lead or co-lead rounds. Rankings are based on F4's proprietary analysis of 1,644+ researched VC firms, scored by data completeness, portfolio depth, investment recency, and stage alignment.
| # | Firm | Check Size | Portfolio | Leads? | Activity | Decision | Intro |
|---|---|---|---|---|---|---|---|
| 1 | ▶ Digitalis Ventures Complex health problems require multidisciplinary teams combining deep technical, financial, and domain expertise. We invest in breakthrough science and technology-enabled solutions across human and animal health. New York | $250K – $50M | 54 | Leads | Active | ~2 mo | Req'd |
| 2 | ▶ Astanor The agrifood value chain has reached a tipping point where incremental change is not enough; systemic disruption and regeneration of the food and agriculture system is required to restore human, planetary, and economic health. Brussels, Belgium | $1M – $25M | 52 | Leads | Active | N/A | N/A |
| 3 | ▶ Seventure Partners Seventure Partners identifies and backs innovative European companies in Life Sciences and Digital Technologies at all stages from seed to pre-IPO, serving as the lead investor and active board-level partner. The firm is a global pioneer in microbiome investing and has built a 25+ year track record of 150+ exits and 30 IPOs. Institutional backing from Natixis Investment Managers/Groupe BPCE provides unique co-investment and network access. Paris | $500K – $10M | 41 | Leads | Active | ~2 mo | Open |
| 4 | ▶ Lerer Hippeau As founder-operators, we see returns in relationships. We back ambitious founders with exceptional vision at the earliest stages with capital, mentorship, and network access. | $100K – $1M | 73 | Leads | Active | ~1 mo | Open |
| 5 | ▶ Redalpine Redalpine backs companies at the convergence of software and science — where rigorous engineering meets scientific breakthroughs. Half the team are scientists, half are operators, enabling them to engage deeply with highly technical founders and support them hands-on from day one through to exit. Primary focus areas: frontier science and biotech, digital health, AI and automation, fintech, synthetic biology, and climate tech. Zug | $500K – $5M | 40 | Leads | Active | N/A | N/A |
| 6 | ▶ Global Brain Broad-spectrum deep-tech and technology investor with particular conviction in AI, climate tech, and healthcare, pairing capital with hands-on operational support and open-innovation partnerships between startups and major Japanese corporations. Tokyo | $2M – $340M | 40 | Both | Active | ~1 mo | N/A |
| 7 | ▶ SEGO Venture Channel capital from a large base of retail and institutional investors into vetted, growth-stage Spanish companies with strong public narratives, giving individual investors direct equity access normally reserved for institutional VC. Madrid | $300K – $10M | 11 | N/A | Active | N/A | N/A |
Investors on this page also frequently invest in these sectors
What other stages do these firms also invest in?
What other sectors do these firms also invest in?
F4 Fund tracks 7 VC firms that actively invest in food & beverage + biotech & life sciences at the Growth stage. These firms are ranked using a composite score that weighs data completeness (30%), portfolio depth (30%), investment recency (25%), and stage alignment (15%).
Based on F4's analysis, the median check size for growth food & beverage + biotech & life sciences investors is $5.3M – $5.3M, with a full range from $100K – $340M. The distribution breaks down as: 1 firms in the $500K-$1M range, 1 firms in the $2M-$5M range, 2 firms in the $5M-$10M range, 3 firms in the $10M+ range.
Among the 7 firms tracked, 86% lead or co-lead rounds. Founders seeking a lead investor should filter for firms marked "Leads" or "Both" in the rankings table above. Lead investors typically set deal terms and anchor the round.
The best growth food & beverage + biotech & life sciences investors combine domain expertise with an active portfolio in the space. Among these firms, 33% prefer warm introductions, and the average firm has 44 portfolio companies. Look for firms whose check size matches your raise, whose stage preference aligns with yours, and who have a track record of supporting companies in your sector through multiple growth phases.
Firm profiles are continuously updated through F4's research pipeline, which combines LLM-powered web research, portfolio analysis, and transcript extraction. The ranking data refreshes every 12 hours. Editorial analysis is reviewed weekly. Individual firm profiles are re-researched on a 30-day cycle or when new information surfaces.